Northern Trust
MXCT icon

Northern Trust’s MaxCyte MXCT Stock Holding History

Northern Trust’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562K Buy
799,709
+53,777
+7% +$50.2K ﹤0.01% 3576
2025
Q4 		$1.16M Sell
745,932
-41,205
-5% -$65.8K ﹤0.01% 3294
2025
Q3 		$1.24M Buy
787,137
+1,293
+0.2% +$2.25K ﹤0.01% 3293
2025
Q2 		$1.71M Sell
785,844
-61,743
-7% -$149K ﹤0.01% 3077
2025
Q1 		$2.31M Sell
847,587
-12,793
-1% -$50.4K ﹤0.01% 2842
2024
Q4 		$3.58M Buy
860,380
+129
+0% +$488 ﹤0.01% 2708
2024
Q3 		$3.35M Buy
860,251
+90,300
+12% +$380K ﹤0.01% 2704
2024
Q2 		$3.02M Sell
769,951
-16,788
-2% -$72.2K ﹤0.01% 2675
2024
Q1 		$3.3M Sell
786,739
-8,347
-1% -$39.2K ﹤0.01% 2717
2023
Q4 		$3.74M Sell
795,086
-2,467
-0.3% -$9.61K ﹤0.01% 2672
2023
Q3 		$2.49M Buy
797,553
+18,923
+2% +$76.1K ﹤0.01% 2815
2023
Q2 		$3.57M Buy
778,630
+17,286
+2% +$79.4K ﹤0.01% 2684
2023
Q1 		$3.77M Buy
761,344
+7,111
+0.9% +$35K ﹤0.01% 2626
2022
Q4 		$4.12M Buy
754,233
+1,882
+0.3% +$11.5K ﹤0.01% 2606
2022
Q3 		$4.89M Buy
752,351
+139,212
+23% +$776K ﹤0.01% 2493
2022
Q2 		$2.9M Sell
613,139
-104,118
-15% -$513K ﹤0.01% 2849
2022
Q1 		$5.01M Buy
717,257
+15,350
+2% +$105K ﹤0.01% 2586
2021
Q4 		$7.15M Buy
701,907
+589,111
+522% +$6.33M ﹤0.01% 2476
2021
Q3 		$1.38M Buy
+112,796
New +$1.7M ﹤0.01% 3435

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Northern Trust's MXCT Position: Q1 2026 in Review

Northern Trust increased its MaxCyte (MXCT) stake by 7.2% in Q1 2026, buying an estimated $50.2K and bringing the position to 799,709 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

Northern Trust first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $7.15M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Northern Trust held 799,709 shares of MaxCyte worth $562K as of Q1 2026.
  • Northern Trust bought 53,777 MaxCyte shares in Q1 2026, an estimated $50.2K.
  • MaxCyte made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3576 holding.
  • Northern Trust first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's MaxCyte position peaked at $7.15M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.